Trial record 3 of 19 for:
ibudilast
Relative Bioavailability of MN-166 (Ibudilast) in Extended Release Tablet vs. Intermediate-release Capsule in Healthy Volunteers
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04054206 |
|
Recruitment Status :
Completed
First Posted : August 13, 2019
Last Update Posted : July 15, 2020
|
Sponsor:
MediciNova
Information provided by (Responsible Party):
MediciNova
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | July 17, 2019 |
| Actual Study Completion Date : | May 31, 2020 |